Senior insider sale
Chief Commercial Officer at ADAPTIMMUNE THERAPEUTICS PLC — senior position signals high conviction
$7.5K
12.99K shares
What this filing means
PICCINA CINTIA plans to sell 12.99K shares of ADAPTIMMUNE THERAPEUTICS PLC valued at approximately $7.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/15/2025ACC: 0001970051-25-000004
Officer· Chief Commercial Officer
Since Jan 2022
12.99K
Shares to sell
$7.5K
Approx. market value
12.99K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Sell to cover exercise (cashless)
COMPENSATION
1/15/2025
12.99KTotal acquired12.99K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2025 | Sell to cover exercise (cashless) COMPENSATION | 12.99K | — |
| Total | 12.99K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
12.99K
Market value
$7.5K
1/15/2025
Total
Units
12.99K
Value
$7.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/15/2025 | 12.99K | $7.5K | NASDAQ | Planned |
| Total | 12.99K | $7.5K | ||